Human aldosterone synthase gene polymorphism promotes miRNA binding and regulates gene expression

Area of Science:

• Genetics
• Molecular Biology
• Cardiovascular Science

Background:

• Hypertension is a significant risk factor for severe cardiovascular and renal diseases.
• The renin-angiotensin-aldosterone system, particularly angiotensin II and aldosterone synthase, plays a critical role in blood pressure regulation.
• Genetic variations in the human Cyp11B2 gene, encoding aldosterone synthase, are linked to hypertension.

Purpose of the Study:

• To investigate the interaction between microRNA-766 (miR-766) and the human Cyp11B2 gene.
• To determine if miR-766 influences aldosterone synthase expression and its potential role in hypertension.

Main Methods:

• Analysis of miR-766 binding to different alleles of the human Cyp11B2 3'-UTR polymorphism (rs28491316).
• Transfection of miR-766 into human adrenocortical H295R cells to assess its effect on aldosterone synthase mRNA and protein levels.

Main Results:

• MicroRNA-766 specifically binds to the 735G allele of the human Cyp11B2 gene, not the 735A allele.
• Transfection with miR-766 led to a significant reduction in human aldosterone synthase mRNA and protein expression in H295R cells.

Conclusions:

• MicroRNA-766 acts as a negative regulator of human aldosterone synthase gene expression.
• These findings suggest a potential mechanism by which miR-766 could influence blood pressure, particularly in individuals with the hypertension-associated -344T allele of the Cyp11B2 gene.